79.20
+0.04
+(0.05%)
At close: 5:32:06 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 9 | 17 | 18 |
| Avg. Estimate | 3.1B | 3.23B | 12.76B | 13.08B |
| Low Estimate | 3.02B | 3.11B | 12.64B | 12.67B |
| High Estimate | 3.21B | 3.32B | 13.32B | 13.71B |
| Year Ago Sales | 3.17B | 3.2B | 13.12B | 12.76B |
| Sales Growth (year/est) | -2.21% | 1.07% | -2.75% | 2.52% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KELL.VI | -- | -- | -- | -- |
| S&P 500 | 8.43% | 11.29% | 13.87% | 13.50% |
Upgrades & Downgrades
| Downgrade | Argus Research: Buy to Hold | 10/2/2024 |
| Maintains | Deutsche Bank: Hold to Hold | 8/15/2024 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 8/15/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 8/15/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 8/15/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 8/15/2024 |